Scarica l'app Stockscreener
5.665
2.49%
-0.155
Precedente Chiudi:
$5.82
Aprire:
$5.77
Volume 24 ore:
1.75M
Relative Volume:
0.28
Capitalizzazione di mercato:
$1.55B
Reddito:
$8.10M
Utile/perdita netta:
$-92.72M
Rapporto P/E:
-15.86
EPS:
-0.3571
Flusso di cassa netto:
$-82.52M
1 W Prestazione:
+2.07%
1M Prestazione:
+37.74%
6M Prestazione:
+122.55%
1 anno Prestazione:
+179.56%
Intervallo 1D:
$5.66
$5.885
Intervallo di 1 settimana:
$5.4615
$5.95
Portata 52W:
$1.05
$5.95
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
Nome
Taysha Gene Therapies Inc
Settore
Industria
Telefono
(214) 612-0000
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Confronta TSHA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
5.675 | 1.59B | 8.10M | -92.72M | -82.52M | -0.3571 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.64 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.08 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
872.32 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
390.58 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
201.83 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Raymond James | Strong Buy |
| 2025-07-11 | Iniziato | BofA Securities | Buy |
| 2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
| 2024-04-09 | Iniziato | Piper Sandler | Overweight |
| 2023-02-01 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | Downgrade | Goldman | Buy → Neutral |
| 2022-03-09 | Iniziato | Robert W. Baird | Outperform |
| 2022-03-01 | Iniziato | Wells Fargo | Overweight |
| 2022-02-18 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-16 | Iniziato | Guggenheim | Buy |
| 2021-07-16 | Iniziato | Needham | Buy |
| 2021-06-24 | Iniziato | Truist | Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-06-09 | Iniziato | Wedbush | Outperform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-05-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-05-11 | Ripresa | Jefferies | Buy |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-01-05 | Iniziato | Oppenheimer | Outperform |
| 2020-10-19 | Iniziato | Chardan Capital Markets | Buy |
| 2020-10-19 | Iniziato | Goldman | Buy |
| 2020-10-19 | Iniziato | Jefferies | Buy |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock By Investing.com - Investing.com Canada
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 1-Year HighTime to Buy? - MarketBeat
Taysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
1,203,941 Shares in Taysha Gene Therapies, Inc. $TSHA Purchased by Stempoint Capital LP - MarketBeat
B Group Inc. Buys 545,000 Shares of Taysha Gene Therapies, Inc. $TSHA - MarketBeat
Taysha Gene Therapies stock hits 52-week high at 5.51 USD - Investing.com
Taysha Gene Therapies stock hits 52-week high at 5.51 USD By Investing.com - Investing.com South Africa
200,000 Shares in Taysha Gene Therapies, Inc. $TSHA Bought by Affinity Asset Advisors LLC - MarketBeat
Taysha Gene Therapies Grants Stock Options to New Employees as Part of Inducement Plan - Quiver Quantitative
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Can Taysha Gene Therapies Stock Hold Up When Markets Turn? - Trefis
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap UpHere's Why - MarketBeat
Taysha Gene Therapies upgraded at Goldman Sachs on advancing Rett syndrome asset - MSN
Would You Still Hold Taysha Gene Therapies Stock If It Fell 30%? - Trefis
Taysha Gene Therapies (TSHA) Upgraded to Buy by Goldman Sachs - GuruFocus
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 7%Still a Buy? - MarketBeat
Taysha Gene Therapies (TSHA) Receives Buy Rating from Goldman Sa - GuruFocus
Goldman Sachs upgrades Taysha Gene Therapies stock rating to Buy By Investing.com - Investing.com Canada
Taysha Gene Therapies (NASDAQ:TSHA) Shares Down 6.5% on Insider Selling - MarketBeat
How Taysha Gene Therapies Inc. stock reacts to oil prices2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Sukumar Nagendran Sells 110,125 Shares of Taysha Gene Therapies (NASDAQ:TSHA) Stock - MarketBeat
Taysha Gene Therapies Insider Sold Shares Worth $1,695,906, According to a Recent SEC Filing - marketscreener.com
Nagendran Sukumar sells Taysha gene therapies (TSHA) shares for $1.69m - Investing.com Canada
TSHA FY2026 EPS Forecast Raised by Cantor Fitzgerald - MarketBeat
How analysts rate Taysha Gene Therapies Inc. stock todayQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Jefferies Financial Group Inc. Acquires 10,068,479 Shares of Taysha Gene Therapies, Inc. $TSHA - MarketBeat
SG Americas Securities LLC Makes New $1.14 Million Investment in Taysha Gene Therapies, Inc. $TSHA - MarketBeat
Will breakout in Taysha Gene Therapies Inc. lead to full recoveryQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.Portfolio Return Report & Growth-Oriented Investment Plans - newser.com
Custom watchlist performance reports with Taysha Gene Therapies Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Will Taysha Gene Therapies Inc. stock recover after recent dropWeekly Risk Report & Safe Capital Preservation Plans - newser.com
How Taysha Gene Therapies Inc. stock benefits from strong dollarJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 2.9%Here's Why - MarketBeat
Why Taysha Gene Therapies Inc. stock is favored by top institutionsJuly 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com
Is Taysha Gene Therapies Inc. (TSHA) One of the Must-Buy Penny Stocks to Buy Now? - MSN
11 Must-Buy Penny Stocks to Buy Now - Insider Monkey
Is Taysha Gene Therapies Inc. stock near bottom after declineJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Can Taysha Gene Therapies Inc. hit a new high this monthTrade Ideas & Weekly High Momentum Picks - newser.com
Can Taysha Gene Therapies Inc. stock sustain institutional interestJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Candlestick signals on Taysha Gene Therapies Inc. stock todayJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Taysha Gene Therapies Inc Azioni (TSHA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar | President and Head of R&D |
Nov 28 '25 |
Option Exercise |
1.07 |
110,125 |
117,363 |
1,116,564 |
| Nagendran Sukumar | President and Head of R&D |
Dec 01 '25 |
Sale |
4.51 |
260,047 |
1,172,812 |
1,006,439 |
| Nagendran Sukumar | President and Head of R&D |
Nov 28 '25 |
Sale |
4.75 |
110,125 |
523,094 |
1,006,439 |
0.12%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):